1. Home
  2. KTTA vs NAII Comparison

KTTA vs NAII Comparison

Compare KTTA & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.51

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Logo Natural Alternatives International Inc.

NAII

Natural Alternatives International Inc.

HOLD

Current Price

$2.37

Market Cap

15.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTTA
NAII
Founded
2020
1980
Country
United States
United States
Employees
5
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.1M
15.8M
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
KTTA
NAII
Price
$0.51
$2.37
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
312.7K
9.8K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$132,437,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.60
52 Week Low
$0.28
$2.09
52 Week High
$2.06
$4.96

Technical Indicators

Market Signals
Indicator
KTTA
NAII
Relative Strength Index (RSI) 37.76 52.60
Support Level $0.42 $2.14
Resistance Level $0.52 $2.52
Average True Range (ATR) 0.04 0.17
MACD 0.00 0.01
Stochastic Oscillator 21.94 63.44

Price Performance

Historical Comparison
KTTA
NAII

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

About NAII Natural Alternatives International Inc.

Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.

Share on Social Networks: